Piper Jaffray has announced the addition of Peter Day as a managing director in the healthcare investment banking group. Day will be based in the firm’s Boston office focused on coverage of the biopharmaceutical sector.
Day brings more than 12 years of healthcare investment banking experience toPiper Jaffray. He joins the firm fromLeerink Swann, where he was a senior calling officer in the healthcare group and was instrumental in building their biopharmaceutical business.
'We are excited to have Peter join our team', commented Chad Abraham, global co-head of investment banking and capital markets at Piper Jaffray. 'We continue to focus investment capital in our healthcare franchise to continue enhancing our highly ranked advisory and equities business. Also, adding a senior calling officer in Boston adds a strategically important coverage area to our biopharmaceutical efforts'.
Bob DeSutter, global head of healthcare investment banking added: 'Our healthcare group is a market-leading platform, serving emerging growth and established clients broadly across life sciences and healthcare services. Peter’s experience serving clients with advisory as well as the full suite of capital market products provides a great fit with our business'.
Piper Jaffrayhas a global healthcare investment banking and capital markets team of 46. Since 2007, the team has represented clients in 200 transactions with an aggregate value of $33bn.
In addition, the firm has 10 senior research analysts covering a broad spectrum of universes, including medical technology, drug discovery, medical diagnostics, life science tools, specialty pharmaceuticals and biotechnology, and healthcare services, including information technology, alternate site providers and contract research.